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Abstract
Escherichia coli strain O157:H7 is a major cause of food poisoning that can result in severe diarrhea and, in some cases, renal
failure. The pathogenesis of E. coli O157:H7 is in large part due to the production of Shiga toxin (Stx), an AB5 toxin that
consists of a ribosomal RNA-cleaving A-subunit surrounded by a pentamer of receptor-binding B subunits. There are two
major isoforms, Stx1 and Stx2, which differ dramatically in potency despite having 57% sequence identity. Animal studies
and epidemiological studies show Stx2 is associated with more severe disease. Although the molecular basis of this
difference is unknown, data suggest it is associated with the B-subunit. Mass spectrometry studies have suggested
differential B-pentamer stability between Stx1 and Stx2. We have examined the relative stability of the B-pentamers in
solution. Analytical ultracentrifugation using purified B-subunits demonstrates that Stx2B, the more deadly isoform, shows
decreased pentamer stability compared to Stx1B (EC50=2.3 mM vs. EC50=0.043 mM for Stx1B). X-ray crystal structures of
Stx1B and Stx2B identified a glutamine in Stx2 (versus leucine in Stx1) within the otherwise strongly hydrophobic interface
between B-subunits. Interchanging these residues switches the stability phenotype of the B-pentamers of Stx1 and Stx2, as
demonstrated by analytical ultracentrifugation and circular dichroism. These studies demonstrate a profound difference in
stability of the B-pentamers in Stx1 and Stx2, illustrate the mechanistic basis for this differential stability, and provide novel
reagents to test the basis for differential pathogenicity of these toxins.
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Introduction
The gastrointestinal pathogen Escherichia coli O157:H7 accounts
for approximately 110,000 cases of disease, 3,200 hospitalizations
and 60 deaths each year in the United States [1]. E. coli O157:H7
illness is most often characterized by self-limiting diarrhea;
however, in approximately 5% of cases disease progresses to a
severe, life-threatening sequela called hemolytic uremic syndrome
(HUS) [2]. HUS is characterized by hemolytic anemia, thrombo-
cytopenia, and renal failure [3]. Progression of disease to HUS
occurs most often in pre-adolescent children and the elderly, and
HUS is the most common cause of acute renal failure in children
[3,4]. Ingesting as few as 50 bacteria can lead to disease [5], and
conventional antibiotic treatment has been reported to enhance
the progression of disease [6]. At present, there is no available
treatment for E. coli O157:H7 infection.
The pathogenic potential of E. coli O157:H7 is due in large part
to its ability to produce a virulence factor called Shiga toxin (Stx).
Stx is a highly potent exotoxin that enters host cells and inhibits
protein synthesis, resulting in cell death [7]. There are two
antigenically distinct forms of Stx (Stx1 and Stx2) which share
57% sequence identity and a highly conserved overall structure
[8]. Strains of E. coli O157:H7 can produce Stx1, Stx2, or both
[9]. Stx2 is far more potent than Stx1 in vivo [10,11], and the
majority of fatal disease cases in humans results from Stx2-
producing E. coli strains [12–15]. Stx is a member of the AB5
family of bacterial toxins [16], composed of an enzymatically
active A-subunit that mediates damage to the host through the
inhibition of protein synthesis [17], and a ring of identical B-
subunits that surround the C-terminus of the A-subunit [18,19].
The B-pentamer binds to the glycolipid globotriaosylceramide
(Gb3) on the surface of host cells and delivers the A-subunit into
the cell [17,20]. Although the basis for the difference in potency
between Stx1 and Stx2 is unclear, the B-subunit plays an
influential role in mediating toxicity [21–25], suggesting that
differences in B-subunit activities, such as receptor recognition or
toxin internalization, are responsible for the variation in potency.
Recently, using mass spectrometry techniques, Kitova et al.
[26,27] reported that Stx1B was primarily pentameric at
concentrations from 5 to 85 mM. These data were supported by
circular dichroism (CD) and dynamic scanning calorimetry (DSC)
studies of Stx1B showing a highly thermostable pentamer [28]. In
contrast, Stx2B was observed to undergo a disassembly transition
in mass spectrometry studies, in which dimer, trimer, tetramer,
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higher-order species at lower concentrations [26,27]. Given
reports that the higher toxicity of Stx2 is due to the contributions
of its B-subunit [21–25], further studies of Stx2B assembly and
behavior are critical for advancing the understanding of Stx-
mediated disease. We have completed a comparative study of the
solution-state assembly and stability of Stx1B and Stx2B and point
mutants using circular dichroism and analytical ultracentrifugation
(AUC), complemented by the X-ray crystal structure of the Stx2B-
Q40L mutant. Overall similarities were observed in the structure
of the proteins, but significant differences occurred in their
solution behavior. Point mutation of a key residue in the inter-
subunit interface to the analogous residue found in the reciprocal
isoform reversed the stability phenotype of the B-subunit, a
valuable first step toward studying the role of B-pentamer
instability in the elevated toxicity of Stx2.
Materials and Methods
Expression Constructs
pET21b(+) expression plasmids (Novagen, Darmstadt, Germany)
encoding the Stx1 and Stx2 B-subunits were generated via
restriction/ligation of genes amplified by polymerase chain reaction
(Table 1). Plasmids were sequenced to verify proper insertion. Site-
directed mutagenesis to generate Stx1B-L41Q and Stx2B-Q40L
mutants was carried out using the Stratagene QuikChangeH II Site-
Directed mutagenesis kit (Agilent Life Sciences, Santa Clara, CA)
according to the manufacturer’s protocol.
Protein Expression
pET21b(+) expression plasmids (Novagen, Darmstadt, Ger-
many) encoding the Stx1 and Stx2 B-subunits were transformed
into E. coli BL21(DE3)pLysS (Novagen). Transformants were
cultured in Luria-Bertani (LB) broth containing ampicillin (250 mg
ml
21) and chloramphenicol (34 mgm l
21)a t3 7 uC, by shaking at
250 rpm until an OD600 value of 1 was reached. Cultures were
cooled to 8uC and B-subunit expression was induced with 0.1 mM
IPTG and 2% ethanol, followed by shaking incubation for 16 h at
20uC. Proteins were extracted by freeze-thaw and sonication.
Protein purification
Stx1B, Stx2B, and Stx2B-Q40L were purified from induced
culture lysates by ammonium sulfate precipitation (40–70%), Q
Sepharose
TM Fast Flow ion exchange chromatography (GE
Healthcare, Uppsala, Sweden), Superdex
TM 75 HiLoad 26/60
size exclusion chromatography (GE Healthcare) and Uno
TM Q6R
ion exchange chromatography (Bio-Rad, Hercules, CA). Stx1B-
L41Q was purified from induced culture lysates by ammonium
sulfate precipitation and pigeon egg white (PEW) affinity
Table 1. Strains and plasmids used in this study.
Relevant Characteristics
a Reference
E. coli strains
BL21(DE3)pLysS T7 strain lysogenized with l-DE3; pLysS plasmid; Chlor
r Novagen
Plasmids
pET21b(+) Expression vector, derived from pBR322 plasmid, Amp
r Novagen
pMFUC-20 pET21b(+)-Stx1B WT, Amp
r This study
pMFUC-21 pET21b(+)-Stx2B WT, Amp
r This study
pSHUC-5 pET21b(+)-Stx1B-L41Q, Amp
r This study
pSHUC-6 pET21b(+)-Stx2B-Q40L, Amp
r This study
aAmp
r, ampicillin-resistant; Chlor
r, chloramphenicol resistant.
doi:10.1371/journal.pone.0015153.t001
Table 2. Crystal and refinement statistics.
Data Collection Stx2B-Q40L
Beamline APS 22-ID
Wavelength (A ˚) 1.000
Space Group C2
Unit Cell (A ˚) a=121.91, b=69.21, c=103.01, b=124.36u
Resolution (A ˚)
a 30.0-2.5 (2.59-2.50)
Observed reflections 82,653
Unique reflections 24,343
Completeness (%) 98.3 (91.1)
Redundancy 3.4 (3.1)
I/s(I) 12.18 (3.77)
Rsym (%)
b 7.1 (23.5)
Refinement
Rwork (%)
c 20.2%
Rfree (%)
d 26.6%
Number of atoms, protein 5,480
Number of atoms, solvent 69
RMSD bonds (A ˚)
e 0.016
RMSD angles (u)
e 1.637
B average, protein (A ˚2) 27.065
B RMSD bonds, main chain (A ˚2) 0.057
B RMSD bonds, side chain (A ˚2) 1.745
Ramachandran Plot [42]:
Most favored 95.7%
Additional allowed 4.0%
Outlier 0.3%
aNumbers in parentheses represent the highest resolution shell.
bRsym=ShSi|Ii(h)-,I(h).|/ShSiI(h).
cRwork=S||Fobs|-|Fcalc||/|Fobs|.
dRfree was calculated using a random 5% of the reflection data that were
withheld from refinement.
eRMSD bonds/RMSD angles are measures of the deviation from ideal values.
doi:10.1371/journal.pone.0015153.t002
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was verified by the presence of a single band at 8 kDa on
Coomassie-stained SDS-PAGE gels. Protein concentrations were
determined using the BCA Protein Assay (Pierce, Rockford, IL).
Analytical ultracentrifugation
AUC experiments were performed in a Beckman XL-I analytical
ultracentrifuge at 20uC with absorbance optics, using a four- or
eight-hole rotor. All experiments were performed in 10 mM
phosphate buffer with 150 mM NaCl at pH 7.4, except where
otherwise noted, at wavelengths ranging from 203 nm to 280 nm.
Protein loading concentrations were determined using the molar
extinction coefficient calculated by ProtParam [31]. Sedimentation
velocity experiments were performed at 48,000 rpm in two-channel
carbon-filled epon centerpieces and data were analyzed using Sedfit
[32]. Sedimentation equilibrium was performed at speeds ranging
from 21,000 to 48,000 rpm and data were analyzed globally using
WinNonlin (www.rasmb.bbri.org). The equilibrium association
constants (K5, units of M
24) for a monomer-pentamer association
were determined with the reduced buoyant molecular weight (s)
fixedatthecalculatedmonomervalue(0.4152 forStx1Band0.4376
for Stx2B at 21,000 rpm). The EC50 (monomer concentration
giving 50% assembly) values reported are the fourth root of the
dissociation constant, in molar units.
Circular Dichroism
Far-UV CD experiments were carried out in an Aviv 215
circular dichroism spectrophotometer using 0.5 mm quartz
cuvettes. Wavelength scans were taken from 195 to 260 nm on
Stx2B wild-type (65 mM), Stx2-Q40L (65 mM), Stx1B (64 mM),
and Stx1-L41Q (49 mM) in 10 mM phosphate buffer with
150 mM NaF at pH 7.4, and converted to mean residue ellipticity
as described [33]. Spectra were deconvoluted using the K2D
module of Dichroweb [34,35]. Temperature melt experiments
were conducted at the same concentrations and buffer conditions,
except for Stx2B-Q40L, which was analyzed at 55 mM protein
concentration in 10 mM phosphate buffer, 150 mM NaCl. The
ellipticity at 219 nm was recorded while the temperature was
increased from 25uCt o9 5 uC in 2 degree increments with 2
minute equilibration to temperature, 5 second averaging time, and
0.2 degree temperature dead band. Fitting for Tm and DH was
done in SigmaPlot 10 (Systat Software, Inc.) using a two-state
model with pre- and post-transition linear changes in ellipticity
[36] as a function of temperature with the following equation:
y~
eDH=RT  
T
Tm
{1

1z eDH=RT  
T
Tm
{1
    uzulT ðÞ { lzllT ðÞ z lzllT ðÞ ½ 
where R is the gas constant (1.987 cal?K
21?mol
21), DH is the
enthalpy, T is the temperature in kelvin, Tm is the midpoint of the
melting transition, u and l are the folded and unfolded limits of the
ellipticity, and ul and ll are the slopes of the linear baseline changes
before and after the unfolding transition, respectively [36].
Figure 1. Differential solution stability of Stx1B and Stx2B
pentamers. A. Sedimentation coefficient distribution plots from
analytical ultracentrifugation sedimentation velocity experiments show
a major peak at ,3 S, which Sedfit estimates to have a molecular
weight consistent with pentamer, at 0.8 to 2 mM loading concentra-
tions. B. The sedimentation coefficient distributions of Stx2B at
concentrations ranging from 0.5 to 8 mM demonstrate significant
differences in solution state assembly. Stx2B appears to be stably
pentameric at 4 to 8 mM, decreasing to mostly monomeric at 0.5 mM. C
and D. Representative plots of sedimentation equilibrium data from
global fits of three concentrations and four speeds in WinNonlin
confirm a monomer-pentamer equilibrium for Stx1B and Stx2B. The K5
and EC50 values determined from these fits are listed in Table 3.
doi:10.1371/journal.pone.0015153.g001
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Stx2B-Q40L was crystallized by hanging drop vapor diffusion in
100 mM HEPES pH 7.1, 200 mM magnesium chloride, and 25%
PEG 3350. Crystals were grown to approximately 200 mm6
200 mm6100 mm, harvested, and cryoprotected in 25% xylitol.
Data was collected at APS beamline 22-ID and indexed and
processed with HKL2000 [37]. Crystals nominally diffract to
2.5 A ˚ and belong to the space group C2 with unit cell dimensions:
(a=121.91 A ˚, b=69.21 A ˚, c=103.01 A ˚). The structure was
determined by molecular replacement using Phaser [38] with
the B-subunit of Stx2 as the search model (PDB ID: 1R4P) [19].
Two Stx2B pentamers are contained within the asymmetric unit.
The model was refined with refmac [39], using TLS and applying
non-crystallographic symmetry restraints, and models were
manually rebuilt with Coot [40]. Crystal data and refinement
statistics are shown in Table 2. The structure was validated with
Procheck [41] and Molprobity [42]. 95.7%, 4%, and 0.3% of the
residues are in the favored, allowed, and outlier regions of the
Ramachandran plot, respectively. PyMOL
TM v1.2 Software
(DeLano Scientific, Palo Alto, CA) was used for the creation of
protein crystal structure figures (www.pymol.org).
Results
Reported results from mass spectrometry (MS) studies have
indicated that Stx1B and Stx2B-pentamer assemblies show
differential stability. Using nanoflow electrospray and Fourier-
Table 3. K5 and EC50 values for Stx1B, Stx2B, Stx1B-L41Q, and Stx2B-Q40L.
Isoform K5 (M
24) 95% confidence interval EC50 (mM)* 95% confidence interval
Stx1B 2.99610
29 1.60610
28 to 1.10610
31 0.043 0.017 to 0.089
Stx1B-L41Q 4.33610
24 1.33610
24 to 1.55610
25 0.693 0.504 to 0.931
Stx2B 3.64610
22 1.33610
22 to 1.06610
23 2.29 1.75 to 2.94
Stx2B-Q40L 7.93610
27 1.22610
27 to 6.38610
28 0.106 0.063 to 0.169
*The EC50 is the fourth root of the dissociation constant.
doi:10.1371/journal.pone.0015153.t003
Figure 2. Prediction of Gln40 as a destabilizing amino acid in
Stx2B. A. Alignment of Stx1B and Stx2B sequences, with identical
residues identified with a dash. Residues L41 and Q40 are marked. B.
Structure of the Stx2 B-pentamer (PDB ID: 1R4P) [19] indicating Gln40
(cyan) and Leu38 (blue). The polar side chain of Gln40 occupies an
otherwise hydrophobic pocket at the interface between a-helices of
adjacent B-subunits. Inset is a zoomed view of Leu38 and Gln40 from
adjacent monomers in Stx2B. The close proximity of Leu38 and Gln40
(,5A ˚) was predicted to disrupt monomer packing. In contrast, a
leucine occupies position 41 in Stx1B, which may help stabilize the
hydrophobic interface between B-subunits.
doi:10.1371/journal.pone.0015153.g002
Figure 3. Sedimentation velocity of reciprocal point mutants.
Sedimentation velocity c(s) traces for Stx1B-L41Q (A) and Stx2B-Q40L (B)
demonstrate a reversal in the pentamer stability in the reciprocal
mutants compared to wild-type. Stx1B-L41Q disassembles over the
same concentration range that Stx1B wt retains stable pentamer
assembly, and Stx2B-Q40L is stabilized relative to wt Stx2B.
doi:10.1371/journal.pone.0015153.g003
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range of assembly states from monomeric to pentameric for Stx2B
at 50 to 65 mM, whereas Stx1B was observed as pentamer at all
concentrations tested (from 5 to 85 mM) [26]. In order to verify the
behavior of Stx1 and Stx2 B-subunits under defined solution
conditions and measure accurate equilibrium association con-
stants, AUC sedimentation velocity and sedimentation equilibrium
experiments were carried out. At concentrations ranging from
0.8 mM (the detection limit of the absorbance optical system) to
2 mM Stx1B was observed to sediment with a predominant ($85%
of signal) species consistent with a pentamer (,35+/22.4 kDa
MW) by sedimentation velocity (Figure 1A). In contrast, the extent
of Stx2B pentamer assembly was reduced over that same
concentration range, with varying sedimentation behavior de-
pending on the loading concentration; pentamer assemblies were
predominant at 8 and 4 mM, and disassembly occurred at
concentrations of 2 mM and lower (Figure 1B).
Quantitative measurements of the Stx B-pentamer stability in
solution were carried out through sedimentation equilibrium AUC
experiments. Equilibrium data from four speeds and three loading
concentrations were globally fitted to determine the stoichiometry
and equilibrium association constants. The data were best
described by a direct monomer-pentamer assembly; the inclusion
of intermediate species did not improve the fits. Molar equilibrium
association constants (K5) are listed in Table 3. The molar
concentration of monomer required to achieve 50% assembly
(EC50), was determined for Stx1B and Stx2B by taking the inverse
fourth root of the molar K5 for each isoform. Figure 1 C and D
show representative plots of data from the global fits. The EC50 of
Stx1B is 0.043 mM, compared to 2.29 mM for Stx2B (Table 3).
This reveals an approximately 50-fold higher stability of the
pentameric assembly for Stx1B compared to Stx2B in the solution
state.
The fifty-fold difference in pentamer stability between Stx
isoforms 1 and 2 was surprising, given that the B-subunits share
66% sequence identity. Examination of the structures for
potentially destabilizing amino acids in the inter-B-subunit
interface revealed a notable difference at position 40 of Stx2B,
which corresponds to amino acid 41 in Stx1B (Figure 2A). Gln40
in Stx2B lies in an otherwise hydrophobic pocket (Figure 2B) and
closely approaches Leu38 (Figure 2B, inset). The corresponding
residue in Stx1B is Leu 41, a hydrophobic residue that may
stabilize the inter-subunit interface (Figure 2A). To test the role of
L41/Q40 in B-pentamer stability, we generated the reciprocal
point mutants Stx1B-L41Q and Stx2B-Q40L.
AUC sedimentation velocity experiments were carried out to
determine the role of residue 40/41 in the assembly of Stx B-
pentamers. The Stx1B-L41Q (Figure 3A) pentamer was destabi-
lized compared to wild-type Stx1B, disassembling to monomer or
lower-order oligomers at concentrations below 4 mM. In contrast,
the reciprocal mutant Stx2B-Q40L (Figure 3B) stabilized the inter-
B-subunit interaction to the extent that the pentameric species
predominated in sedimentation velocity experiments down to
0.5 mM, the detection limit of the absorbance optics. CD
wavelength scans were used to compare the secondary structure
content of wild-type and mutant B-pentamers to rule out large-
scale structural deviations. The far-UV CD spectra of Stx1B and
Stx1B-L41Q superimposed (Figure 4A), as did the spectra of
Stx2B and Stx2B-Q40L (Figure 4B). Deconvolution of the
secondary structures using the K2D module in Dichroweb
[34,35] showed no significant changes in secondary structure
content. These studies indicated that any differences observed in
the degree of pentamer assembly were not due to gross deviations
in secondary structure caused by the mutations.
Sedimentation equilibrium studies quantitatively demonstrated
the reversal in B-pentamer stability. Representative data curves
taken from a global analysis of multiple datasets fitted to a
monomer-pentamer assembly model showed the differences in
assembly clearly (Figure 5). At a 2 mM loading concentration and
25K rpm rotor speed, pentamers were the major species at
equilibrium for both wild-type Stx1B (Figure 5A) and Stx2B-Q40L
(Figure 5D). EC50 values, calculated from the K5 values, were
0.043 and 0.106 mM for Stx1B and Stx2B-Q40L, respectively
(Table 3). In contrast, Stx2B wild-type and Stx1B-L41Q showed a
mix of monomer and pentamer contributions, with EC50 values of
2.29 mM (Stx2B) and 0.693 mM (Stx1B-L41Q). These data
showed the remarkable ability of a single amino acid within the
pentamer subunit interface to alter the stability of the pentameric
assembly state.
Differential pentamer stability between the Stx1 and Stx2
isoforms and mutants would be expected to alter their apparent
unfolding transition, since stabilizing a subunit interface will
Figure 4. Circular dichroism spectra of wild-type and mutant
proteins. A. Stx1B wild-type and L41Q mutant CD wavelength spectra.
The far-UV spectra overlay, suggesting that no large-scale changes in
secondary structure occur in the L41Q point mutant. B. Stx2B wild-type
and Q40L mutant CD spectra. The spectra overlay, supporting the
structural similarity between wild-type and Q40L mutant proteins.
doi:10.1371/journal.pone.0015153.g004
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carried out thermal denaturation studies using far-UV CD
spectroscopy in order to determine the Tm, the temperature at
which 50% of the protein is denatured [36]. CD measurements of
the ellipticity at 219 nm as a function of temperature revealed that
the Q40L mutation raised the Tm of Stx2B by 18uC relative to
wild-type Stx2B, whereas the reciprocal mutation L41Q in Stx1B
lowered the Tm by at least 15uC relative to wild-type Stx1B
(Figure 6) (the unfolding transition for Stx1B was not completed by
95uC and thus could not be determined precisely). Both Stx2B and
Stx2B-Q40L (Figure 6B) were reversible under the scan conditions
tested; however, Stx1B and Stx1B-L41Q (Figure 6A) were not,
and therefore the fitted parameter values may only be used for
internal comparisons. These data corroborate the AUC data,
demonstrating stability reversal for the Stx1B-L41Q and Stx2B-
Q40L mutants. The Tm and DH values from fits of the CD t-melt
data support a two state (folded pentamer to unfolded monomer)
model (Table 4), which assumes that dissociation of the pentamer
is concomitant with denaturation of the monomer.
X-ray crystallographic studies (Table 2) of Stx2B-Q40L were
undertaken to gain better insight into molecular packing at the
inter-B-subunit interface. As expected based on the CD data, no
global structural changes were observed in an overlay of the Ca
traces of a single B-subunit of wild-type Stx2B and Stx2B-Q40L
(average RMSD =0.37 A ˚) (Figure 7). However, a deviation in the
position of the L40 side chain was observed in the mutant protein.
The leucine in the mutant packs well into the hydrophobic pocket
of the adjacent subunit, whereas the wild-type glutamine residue
appears to be offset from the groove (Figure 8A and B). This
confirmed the CD data indicating that the change in solution
behavior was not due to any large-scale structural changes, but
rather the destabilizing effect of the unfavorable presence of the
polar side-chain of Q40 in an otherwise hydrophobic pocket.
Discussion
Previous work has made it clear that the B-subunits are critical
determinants of the differential toxicity of Stx1 and Stx2 in vivo.I n
cell-free in vitro translation inhibition assays, Stx1 and Stx2 A-
subunit toxicities are indistinguishable, suggesting that the
enzymatic activities of these subunits are not responsible for the
large in vivo differences between the two toxins [21–25]. In
contrast, animal models comparing wild-type and chimera Stx
toxicity demonstrate that the presence of the Stx2 B-subunit is a
critical determinant of lethality in vitro and in vivo [21–25].
Therefore, analyses of variation in the stability and assembly of
Figure 5. Representative species concentration plots of monomeric and pentameric B-subunits from sedimentation equilibrium
data. Stx1B (A) and Stx2B-Q40L (D) show predominantly pentamer species. Stx2B (B) is primarily monomeric, whereas Stx1B-L41Q (C) retains a
mixture of monomer and pentamer species. K5 and EC50 values for these data are listed in Table 3.
doi:10.1371/journal.pone.0015153.g005
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basis of differential toxicity between Stx1 and Stx2. This research
presents a quantitative assessment of solution-state differences in
Stx B-pentamer assembly. The difference previously observed by
mass spectrometry methods [26,27] was confirmed and quantified
in a direct solution-state technique. The Stx2 B-pentamer is
approximately 50 times less stable in solution at pH 7.4 than Stx1
B-pentamer. The equilibrium sedimentation data could be
described sufficiently by a monomer-pentamer association model
without inclusion of intermediate species. Although the sedimen-
tation coefficient distribution plots showed peaks at intermediate
positions between the monomer and pentamer peaks (Figs. 1B,
3A), these do not necessarily represent true intermediate
oligomeric states but rather weighted averages of the populations
of monomers and pentamers in fast equilibrium relative to the
time scale of the sedimentation experiment [43,44].
Interestingly, the AUC sedimentation equilibrium K5 values for
Stx1B and Stx2B-Q40L were within error of one another, while
those of Stx2B and Stx1B-L41Q were not. This suggests that while
Q40/L41 has a significant affect on B-pentamer stability, other
residues are likely to also contribute. Our CD data further
supports the involvement of additional residues. The Tm of Stx2B-
Q40L is increased 18uC relative to Stx2B wild-type, but it is not
within error of Stx1B. The L41Q mutation decreases the Tm of
Stx1B by 15uC, but Stx1B-L41Q remains more stable than Stx2B.
Additional interactions must account for the 5 to 9 degree offset in
Tm between wild-type and reciprocal mutants of the opposing
isoform. One candidate residue is R69, which participates in a salt
bridge in Stx1B; Stx2B lacks such an interaction between the
corresponding residues. Kitova et al. observed a loss of Stx1B
stability upon mutation of R69 to glutamate, a charge reversal that
disrupts the salt bridge [27].
The Q40/L41 side chains, although buried in the interface
between B-subunits in the context of the B-pentamer, are found on
the surface of each subunit monomer. Thus, the difference in
thermal stability between wild-type and mutant B-subunits
observed in CD experiments is not likely to be due to disruption
of the hydrophobic core of each monomer. Rather, favorable
packing of the inter-subunit interface stabilizes the pentamer
assembly, which results in a higher Tm for Stx1B and Stx2B-
Q40L. Thus, the two-state model used to fit the CD thermal
denaturation data is an oversimplification, since it does not
explicitly account for disassembly of the pentamer separately from
Figure 6. Thermal denaturation of Stx isoforms and mutants. A.
Stx1B (black) and Stx1B-L41Q (gray) thermal denaturation curves. Stx1B-
L41Q is destabilized (decreased melting temperature) compared to
wild-type Stx1B. B. Stx2B (black) and Stx2B-Q40L (gray) thermal
denaturation curves show that Stx2B-Q40L has an increased thermal
stability relative to wild-type Stx2B. Parameters from the fits can be
found in Table 4.
doi:10.1371/journal.pone.0015153.g006
Table 4. Thermodynamic parameters from CD T-melt fits.
Isoform DH (kcal/mol) Tm (6C)
Stx1B* 2130+/253 91.1+/24.3{
Stx1B-L41Q* 276.1+/218 76.1+/21.4
Stx2B 279.4+/25.2 67.2+/20.2
Stx2B-Q40L 2100+/29.4 85.6+/20.7
*These melts were irreversible under the scan conditions tested.
{Protein did not completely melt under the scan conditions reported. The Tm is
likely $91uC.
doi:10.1371/journal.pone.0015153.t004
Figure 7. Superimposed crystal structures of Stx2B and Stx2B-
Q40L subunits. Alpha-carbon traces from a representative B-subunit
from the published structure of wild-type Stx2 (gray) (PDB ID: 1R4P) [19]
and Stx2B-Q40L (green) overlay. The backbone RMSD of 0.260 to
0.555 A ˚ indicates no major structural rearrangements occurred in the
Stx2B-Q40L mutant.
doi:10.1371/journal.pone.0015153.g007
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analysis of pentamer stability via accurate determination of Tm,
the parameter that can be determined with highest confidence
from CD thermal denaturation data [45]. Explicit Nmer unfolding
models are well developed for trimeric and tetrameric systems;
however, higher-order models that explicitly describe oligomer
dissociation linked to monomer unfolding are too complex to
resolve using CD t-melts [36]. Previous studies of Stx1B
thermostability have reported no improvement in fits with models
that include folded monomer as an intermediate [28,46,47]. This
does not preclude the presence of folded monomer, but merely
indicates that folded monomer may be indistinguishable from
folded pentamer species in the CD spectra.
Mutation of Stx1B residue L41 has previously been used to
destabilize inter-subunit packing [46]. Stx1B-L41W decreased the
Tm by 6uC in CD thermal melts. Transport of destabilized Stx1B
into the cytoplasm was then assessed by MHC presentation assays,
which showed that destabilization did not enhance entry into the
cytoplasm. However, there is no data for how B-pentamer stability
affects toxin efficacy. Destabilization of the B-pentamer may not
affect entry, but a less stable toxin might more readily deliver the
toxic A-subunit once internalized.
The physiological significance of the differences in B-pentamer
stability is currently unclear. Numerous subtypes of Stx1 and Stx2
have been identified. The Stx2a-g subtypes display differences in
potency and host range specificity. Some of the most polymorphic
regions of Stx2 are involved in receptor recognition [48–50],
suggesting that these changes confer a selective advantage, likely
by altering host range specificity. In contrast, the destabilizing
glutamine of Stx2 and the stabilizing leucine of Stx1 are highly
conserved among their respective subtypes [49,51], suggesting that
there may be a selective advantage to maintain the phenotypes
conferred by these amino acids. Studies to determine the degree to
which the Stx2 holotoxin is also destabilized by the glutamine need
to be performed. However, given the potency of Stx2 and the large
amount of material needed to perform the biophysical character-
izations reported in this study, such studies should be performed
with detoxified material. Efforts to prepare genetically toxoided
forms of the holotoxin are currently in progress.
Acknowledgments
The authors would like to thank Scott Millen, Sarah Hall and Bilal Jilani
for technical assistance. The atomic coordinates and structure factors for
Stx2B-Q41L have been deposited in the RCSB protein data bank (PDB
code 3MXG).
Author Contributions
Conceived and designed the experiments: DGC MJF DRF RAK AAW
ABH. Performed the experiments: DGC MJF DRF BDVW. Analyzed the
data: DGC MJF DRF BDVW RAK AAW ABH. Wrote the paper: DGC
MJF DRF BDVW RAK AAW ABH.
References
1. Centers for Disease Control and Prevention. (2005) Disease listing, enterohe-
morrhagic E. coli.
2. Mead PS, Griffin PM (1998) Escherichia coli O157:H7. Lancet 352(9135):
1207–1212.
3. Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the
hemolytic-uremic syndrome. N Engl J Med 333(6): 364–368.
4. Siegler RL (1995) The hemolytic uremic syndrome. Pediatr Clin North Am
42(6): 1505–1529.
5. Tilden J, Jr., Young W, McNamara AM, Custer C, Boesel B, et al. (1996) A new
route of transmission for Escherichia coli: Infection from dry fermented salami.
Am J Public Health 86(8): 1142–1145.
6. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the
hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7
infections. N Engl J Med 342(26): 1930–1936.
7. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, et al. (1988) Site of
action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on
eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem
171(1-2): 45–50.
8. Proulx F, Seidman EG, Karpman D (2001) Pathogenesis of Shiga toxin-
associated hemolytic uremic syndrome. Pediatr Res 50(2): 163–171.
9. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, et al. (1997) Escherichia
coli O157:H7 diarrhea in the united states: Clinical and epidemiologic features.
Ann Intern Med 126(7): 505–513.
10. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, et al. (2003) Response
to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
Pediatr Nephrol 18(2): 92–96.
11. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, et al. (1993)
Comparison of the relative toxicities of Shiga-like toxins type I and type II for
mice. Infect Immun 61(8): 3392–3402.
12. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, et al. (1989) Toxin
genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia
coli O157:H7 infections. J Infect Dis 160(6): 994–998.
13. Orth D, Grif K, Khan AB, Naim A, Dierich MP, et al. (2007) The Shiga toxin
genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin
in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn
Microbiol Infect Dis 59(3): 235–242.
14. Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, et al. (1990)
Haemolytic uraemic syndromes in the British Isles, 1985-8: Association with
verocytotoxin producing Escherichia coli. part 2: Microbiological aspects. Arch Dis
Child 65(7): 722–727.
Figure 8. Side-chain packing for Stx2B and Stx2B-Q40L. A. A
cartoon model of a single wild-type Stx2B subunit with a space-filling
model of the Q40 side chain is shown in gray, and the surface of the
adjacent B-subunit is colored by charge (blue = positive, red =
negative, white = neutral). The oxygen and nitrogen atoms (colored
red and blue, respectively) of the Q40 side chain lie in an unfavorable
position in the inter-subunit interface. B. By contrast, the Stx2B-Q40L
mutant (in green) shows the L40 side chain tightly packed into the
hydrophobic pocket.
doi:10.1371/journal.pone.0015153.g008
Stability of Stx1 and Stx2 B-Pentamers
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e1515315. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999)
Associations between virulence factors of Shiga toxin-producing Escherichia coli
and disease in humans. J Clin Microbiol 37(3): 497–503.
16. Merritt EA, Hol WG (1995) AB5 toxins. Curr Opin Struct Biol 5(2): 165–171.
17. Donohue-Rolfe A, Keusch GT, Edson C, Thorley-Lawson D, Jacewicz M
(1984) Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of
Shigella toxin and characterization of subunit composition and function by the
use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med 160(6):
1767–1781.
18. Fraser ME, Chernaia MM, Kozlov YV, James MN (1994) Crystal structure of
the holotoxin from Shigella dysenteriae at 2.5 A ˚ resolution. Nat Struct Biol 1(1):
59–64.
19. Fraser ME, Fujinaga M, Cherney MM, Melton-Celsa AR, Twiddy EM, et al.
(2004) Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol
Chem 279(26): 27511–27517.
20. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT (1986)
Pathogenesis of Shigella diarrhea. XI. isolation of a shigella toxin-binding
glycolipid from rabbit jejunum and HeLa cells and its identification as
globotriaosylceramide. J Exp Med 163(6): 1391–1404.
21. Head SC, Karmali MA, Lingwood CA (1991) Preparation of VT1 and VT2
hybrid toxins from their purified dissociated subunits. evidence for B subunit
modulation of a subunit function. J Biol Chem 266(6): 3617–3621.
22. Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends
Microbiol 4(4): 147–153.
23. Marcato P, Vander Helm K, Mulvey GL, Armstrong GD (2003) Serum amyloid
P component binding to Shiga toxin 2 requires both a subunit and B pentamer.
Infect Immun 71(10): 6075–6078.
24. Weinstein DL, Jackson MP, Perera LP, Holmes RK, O’Brien AD (1989) In vivo
formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and
role of the B subunit in localization and cytotoxic activity. Infect Immun 57(12):
3743–3750.
25. Nelson S (1994) In: Karmali MA, Golgio AG, eds. Recent advances in
verocytotoxin-producing Escherichia coli infections. Elsevier Science. pp 245–248.
26. Kitova EN, Daneshfar R, Marcato P, Mulvey GL, Armstrong G, et al. (2005)
Stability of the homopentameric B subunits of Shiga toxins 1 and 2 in solution
and the gas phase as revealed by nanoelectrospray fourier transform ion
cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 16(12):
1957–1968.
27. Kitova EN, Mulvey GL, Dingle T, Sinelnikov I, Wee S, et al. (2009) Assembly
and stability of the Shiga toxins investigated by electrospray ionization mass
spectrometry. Biochemistry 48(23): 5365–5374.
28. Pina DG, Gomez J, Villar E, Johannes L, Shnyrov VL (2003) Thermodynamic
analysis of the structural stability of the Shiga toxin B-subunit. Biochemistry
42(31): 9498–9506.
29. Tomoda H, Arai M, Koyama N, Matsui H, O mura S, et al. (2002) Purification
of Shiga-like toxin 1 by pigeon egg white glycoproteins immobilized on
sepharose gels. Anal Biochem 311(1): 50–56.
30. Miyake M, Utsuno E, Noda M (2000) Binding of avian ovomucoid to Shiga-like
toxin type 1 and its utilization for receptor analog affinity chromatography. Anal
Biochem 281(2): 202–208.
31. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, et al. (2005)
Protein identification and analysis tools on the ExPASy server. In: Walker JM,
ed. The Proteomics Protocols Handbook. : Humana Press. pp 571–607.
32. Schuck P (2000) Size-distribution analysis of macromolecules by sedimentation
velocity ultracentrifugation and Lamm equation modeling. Biophys J 78(3):
1606–1619.
33. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, et al. (2008) A zinc-
dependent adhesion module is responsible for intercellular adhesion in
staphylococcal biofilms. Proc Natl Acad Sci U S A 105(49): 19456–19461.
34. Andrade MA, Chacon P, Merelo JJ, Moran F (1993) Evaluation of secondary
structure of proteins from UV circular dichroism spectra using an unsupervised
learning neural network. Protein Eng 6(4): 383–390.
35. Whitmore L, Wallace BA (2008) Protein secondary structure analyses from
circular dichroism spectroscopy: Methods and reference databases. Biopolymers
89(5): 392–400.
36. Greenfield NJ (2006) Using circular dichroism collected as a function of
temperature to determine the thermodynamics of protein unfolding and binding
interactions. Nat Protoc 1(6): 2527–2535.
37. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in
oscillation mode. Method Enzymol 276: 307–326.
38. Storoni LC, McCoy AJ, Read RJ (2004) Likelihood-enhanced fast rotation
functions. Acta Crystallogr D Biol Crystallogr 60(Pt 3): 432–438.
39. Winn MD, Isupov MN, Murshudov GN (2001) Use of TLS parameters to model
anisotropic displacements in macromolecular refinement. Acta Crystallogr DBiol
Crystallogr 57(Pt 1): 122–133.
40. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1): 2126–2132.
41. Laskowski RA, Macarthur MW, Moss DS, Thornton JM (1993) Procheck - a
program to check the stereochemical quality of protein structures. Journal of
Applied Crystallography 26: 283–291.
42. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007)
MolProbity: All-atom contacts and structure validation for proteins and nucleic
acids. Nucleic Acids Res 35 (Web Server issue): W375–83.
43. Correia JJ, Alday PH, Sherwood P, Stafford WF (2009) Effect of kinetics on
sedimentation velocity profiles and the role of intermediates. Methods Enzymol
467: 135–161.
44. Gilbert GA (1959) Sedimentation and electrophoresis of interacting substances I.
Idealized boundary shape for a single substance aggregating reversibly.
Proceedings of the Royal Society of London. Series A. Mathematical and
Physical Sciences 250: 377–388.
45. Fersht A (1999) Structure and mechanism in protein science: A guide to enzyme
catalysis and protein folding. New York: W.H. Freeman. 631 p.
46. Pina DG, Stechmann B, Shnyrov VL, Cabanie L, Haicheur N, et al. (2008)
Correlation between Shiga toxin B-subunit stability and antigen crosspresenta-
tion: A mutational analysis. FEBS Lett 582(2): 185–189.
47. Pina DG, Gomez J, England P, Craescu CT, Johannes L, et al. (2006)
Characterization of the non-native trifluoroethanol-induced intermediate
conformational state of the Shiga toxin B-subunit. Biochimie 88(9): 1199–1207.
48. Kulkarni AA, Fuller C, Korman H, Weiss AA, Iyer SS (2010) Glycan
encapsulated gold nanoparticles selectively inhibit Shiga toxins 1 and 2.
Bioconjug Chem 21(8): 1486–1493.
49. Lee JE, Reed J, Shields MS, Spiegel KM, Farrell LD, et al. (2007) Phylogenetic
analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease
outbreaks. BMC Microbiol 7: 109.
50. Ling H, Pannu NS, Boodhoo A, Armstrong GD, Clark CG, et al. (2000) A
mutant Shiga-like toxin IIe bound to its receptor gb(3): Structure of a group II
Shiga-like toxin with altered binding specificity. Structure 8(3): 253–264.
51. Asakura H, Makino S, Kobori H, Watarai M, Shirahata T, et al. (2001)
Phylogenetic diversity and similarity of active sites of Shiga toxin (stx) in Shiga
toxin-producing Escherichia coli (STEC) isolates from humans and animals.
Epidemiol Infect 127(1): 27–36.
Stability of Stx1 and Stx2 B-Pentamers
PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e15153